RecruitingNot Applicable

Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery

United States2,000 participantsStarted 2026-02-01

Plain-language summary

The implementation of the AI-assisted radiology summary tool into clinical workflows is being conducted as part of a standard-of-care quality improvement (QI) initiative at UW Health. The evaluation of this tool's impact via structured feedback from patients and providers is being undertaken as a prospective research study.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria (Patient Participants): * Age 18 years or older * Having a current or prior cancer diagnosis (any cancer type) * Has active access to the UW Health MyChart patient portal. * Receiving care at UW Health within the Division of Hematology, Medical Oncology and Palliative Care or Department of Gynecologic Oncology. * Undergoing imaging studies (such as CT, MRI, or PET scans) as part of routine cancer care. * Willing and able to complete electronic REDCap surveys. * For interview participation: willing to participate in a 30-45-minute phone or video interview. Inclusion Criteria (Provider Participants): Cancer care providers will be eligible to participate in this study if they meet all of the following criteria: * Faculty physician (MD or DO) practicing in the Division of Hematology, Medical Oncology and Palliative Care or Department of Gynecologic Oncology at UW Health. * Involved in reviewing, discussing, or sharing imaging results with patients. * Planned to gain access to the AI-assisted, patient-friendly imaging summary tool as part of clinical implementation. * Willing and able to complete electronic surveys or participate in a brief interview (\~30 minutes). Exclusion Criteria (Patients): * Are unable to provide informed consent due to cognitive impairment or other limitations, as determined by the clinical or study team. * Enrolled in an active interventional clinical trial. Patients on biospecimen, registry, or non-interventional studies are eligi…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Proportion of Patient Participants who report the information presented in their results is "Somewhat easy to understand" or "Very easy to understand" when reviewed by themselves

Timeframe: up to 15 minutes

Perceived impact of scan-result-related patient queries on Provider Participant workload

Timeframe: baseline, 3 months

Trial details

NCT IDNCT07532083

SponsorUniversity of Wisconsin, Madison

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-01

Contact for this trial

Supportive Oncology

608-263-6002 supportiveoncology@uwcarbone.wisc.edu

View on ClinicalTrials.gov More Oncology trials